The Research and Development Team at Lassen Therapeutics is responsible for discovering and developing novel biotherapeutics. They conduct preclinical research to identify promising drug candidates, advance understanding of disease biology, and translate scientific discoveries into potential treatments. This team collaborates across various disciplines to ensure the therapeutic efficacy and safety of new drugs, with a focus on improving outcomes for patients with serious diseases.
Andrew Nash
Scientific Advisor
Bill Bradford
Scientific Advisor
Cory Hogaboam
Scientific Advisor
Deborah Witherden
Senior Scientist, Cell Biology...
Jamie Swaney
VP, Fibrosis & Translational B...
Matthias Ernst
Scientific Advisor
Mike Gallatin
Scientific Advisor
Paul Noble
Scientific Advisor
Toby Maher
Scientific Advisor
Toni Jun
VP, Preclinical Development
View all